Mineralys Therapeutics appoints Dr. Alexander Gold to board; Dr. Olivier Litzka resigns

Mineralys Therapeutics, Inc.

Appointed Alexander M. Gold, M.D. as Class I director and to Nominating and Corporate Governance Committee, effective June 13, 2024.
Dr. Gold received options to purchase 44,000 shares vesting over three years; cash compensation per non-employee director program.
Dr. Olivier Litzka resigned from board effective June 13, 2024, with no disagreement with company or management.
Board size decreased from eight to seven following resignation and prior departure of Alexander Asam, Ph.D. on May 22, 2024.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Olivier Litzka

Director

MLYS · Mineralys Therapeutics, Inc.

Effective: 2024-06-13
Filed: June 14, 2024, 7:59 PM ET

Olivier Litzka, Ph.D. informed the Board of his decision to resign from the Board, effective June 13, 2024.

Appointed

Alexander M. Gold

Class I director

MLYS · Mineralys Therapeutics, Inc.

Effective: 2024-06-13
Filed: June 14, 2024, 7:59 PM ET

the Board appointed Alexander M. Gold, M.D. as a member of the Board and the Nominating and Corporate Governance Committee of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Olivier Litzka resigned as Director at Mineralys Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

Olivier Litzka, Ph.D. informed the Board of his decision to resign from the Board, effective June 13, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Alexander M. Gold was appointed as Class I director at Mineralys Therapeutics, Inc..

Action: appointed
Role: Class I director

Exact text from the filing

the Board appointed Alexander M. Gold, M.D. as a member of the Board and the Nominating and Corporate Governance Committee of the Board.

View on SEC.gov

Mineralys Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001933414-24-000028

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.